Researchers have been excited about the medication , a groundbreaking dual treatment showing remarkable outcomes in initial trials for body loss . It acts by modulating both hormones : GLP-1 and GIP, that , when activated , help control hunger and enhance metabolism . Initial reports indicate noteworthy size reduction and likely advantages for indi